INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 147 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $463,000 | +20.3% | 36,606 | 0.0% | 0.01% | +11.1% |
Q1 2017 | $385,000 | +14.2% | 36,606 | 0.0% | 0.01% | +12.5% |
Q4 2016 | $337,000 | -22.0% | 36,606 | 0.0% | 0.01% | -20.0% |
Q3 2016 | $432,000 | -64.4% | 36,606 | -13.7% | 0.01% | -65.5% |
Q4 2015 | $1,215,000 | -16.4% | 42,427 | -17.0% | 0.03% | -21.6% |
Q3 2015 | $1,454,000 | -60.8% | 51,097 | -50.5% | 0.04% | -53.8% |
Q2 2015 | $3,706,000 | +3.7% | 103,168 | +67.8% | 0.08% | +14.3% |
Q1 2015 | $3,574,000 | +193.7% | 61,479 | +113.0% | 0.07% | +218.2% |
Q4 2014 | $1,217,000 | +8.7% | 28,869 | 0.0% | 0.02% | +15.8% |
Q3 2014 | $1,120,000 | +104.0% | 28,869 | +64.3% | 0.02% | +111.1% |
Q2 2014 | $549,000 | -24.6% | 17,569 | -0.0% | 0.01% | -25.0% |
Q1 2014 | $728,000 | +4.3% | 17,570 | -2.5% | 0.01% | 0.0% |
Q4 2013 | $698,000 | -56.5% | 18,023 | -60.7% | 0.01% | -58.6% |
Q3 2013 | $1,605,000 | – | 45,884 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |